Alexandria Real Estate Equities, Inc. (ARE) Covered Calls

Alexandria Real Estate Equities, Inc. (ARE) is the pioneer and leading owner-operator of collaborative life science megacampuses in AAA innovation clusters. The company provides high-quality laboratory and office space to the world top pharmaceutical, biotechnology, and technology firms. Focusing on high-barrier markets like Greater Boston, San Francisco, and San Diego, Alexandria creates integrated environments that foster scientific discovery and help tenants attract world-class talent.

You can sell covered calls on Alexandria Real Estate Equities, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ARE (prices last updated Fri 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Alexandria Real Estate Equities, Inc. (ARE) is a specialized urban office REIT that focuses exclusively on life science and technology campuses. Established in 1994, Alexandria pioneered the "lab space" asset class and has since built a dominant position in the most productive innovation clusters in North America. The company strategy revolves around its "Megacampus" model—large-scale, integrated ecosystems that provide life science companies with not only state-of-the-art laboratory facilities but also the amenities and collaborative spaces necessary to drive R&D productivity.

Core Business and Products

The company primary revenue driver is its portfolio of high-end laboratory and office properties, which are concentrated in core markets such as Greater Boston, the San Francisco Bay Area, San Diego, and New York City. Alexandria differentiates itself by catering to high-quality, "sticky" tenants, with over 50% of its annual rental revenue coming from investment-grade or large-cap publicly traded companies like Eli Lilly, Moderna, and Bristol-Myers Squibb. In addition to real estate, the company operates Alexandria Venture Investments, a strategic venture capital arm that invests in early-stage life science and agtech companies, providing the firm with deep insights into emerging scientific trends and potential future tenants.

Competitive Landscape

1. BXP, Inc. (formerly Boston Properties) is a major office REIT that competes with Alexandria for high-end office and lab tenants, particularly in the Boston and San Francisco markets.
2. Prologis, Inc., while focused on logistics, represents competition for institutional real estate capital and land for development in key coastal markets where Alexandria operates.
3. Vornado Realty Trust competes in the New York City market for high-profile office and life science development projects, targeting similar technology-focused corporate tenants.
4. Equinix, Inc. is a specialized REIT that, like Alexandria, manages mission-critical infrastructure, competing for investor capital allocated to specialized "niche" real estate sectors.
5. Healthpeak Properties, Inc. (PEAK) is a direct competitor in the life science real estate sector, owning and developing lab and office space across major U.S. biotech clusters.

Strategic Outlook and Innovation

The strategic focus for Alexandria in 2026 is navigating the post-pandemic stabilization of the lab space market while maintaining its premium rental rates. In early 2026, the company broke ground on a massive 466,598 square foot biomedical research center for Novartis in San Diego, highlighting its continued ability to secure long-term commitments from major pharmaceutical players. Management has set 2026 earnings guidance at $6.25 to $6.55 per share, supported by a robust development pipeline and high occupancy rates across its core megacampuses. The company continues to prioritize a flexible balance sheet with significant liquidity to fund opportunistic acquisitions during periods of market volatility.

Innovation at Alexandria is centered on "future-proofing" its facilities to meet the evolving needs of advanced modalities like cell and gene therapy. The company is investing in modular lab designs and highly specialized air filtration and power systems that can support the intense technical requirements of modern biotech research. Additionally, Alexandria is expanding its commitment to sustainability, with a significant portion of its portfolio achieving LEED Gold or Platinum certification. By integrating environmental stewardship with its high-touch operational model, Alexandria aims to remain the partner of choice for the world most innovative life science organizations.

Want more examples? ARDX Covered Calls | ARES Covered Calls